Hammarskiöld acted as legal adviser to Biosergen AB (publ) (“Biosergen”) in connection with a rights issue of shares and warrants. Biosergen’s shares are listed on Nasdaq First North Growth Market in Stockholm.
For more information, please see Biosergen’s press release HERE.
Hammarskiöld’s team consisted of:
Carl-Johan Pousette (Partner)
Aksel Ahlqvist (Senior Associate)
Kelin Taylor Lundgren (Associate)